Latest Reports

The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.

This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2025 Exudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of anti-VEGFs and other therapies for exudative retinal diseases. It highlights key market trends, growth drivers, and future opportunities, with five-year forecasts in units and dollars for branded ocular anti-VEGFs, cancer drugs used off-label, biosimilars, and sustained-drug-delivery devices. The report also breaks down market share by product category and profiles 29 leading competitors, detailing their products, strategies, and market positioning. 

The “2025 Premium Cataract Surgery Market Report” delivers a clear view of the world’s leading PCS markets, covering 13 countries that together generate 84 percent of global PCS manufacturer revenue. From the United States and China to Japan, Germany, and beyond, each market is analyzed in depth, highlighting key trends, growth drivers, and strategic opportunities. 

The report zeroes in on the factors that matter most for companies evaluating market potential or planning to launch premium cataract surgery devices, providing actionable insights to guide investment and expansion decisions. 

The “2025 Nonexudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of current and emerging therapies for geographic atrophy, dry AMD, and other nonexudative retinal diseases. It evaluates complement inhibitors, gene therapies, sustained-release technologies, antioxidants, and more—examining key market trends, patient economics, reimbursement dynamics, and five-year growth forecasts.  

The report also includes detailed unit and dollar demand projections, product category market shares, and profiles of 19 leading competitors with insights into their strategies and outlooks. 

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

Market Scope surveyed ophthalmologists and optometrists in the US and Western Europe (WE) during July and August 2025 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends. 

Ophthalmologists and optometrists from most specialties (cataract, refractive, retina, dry eye glaucoma, and comprehensive) who self-registered on market-scope.com were invited to participate in the annual sponsored survey. 

An email invitation was sent on July 25, 2025, and a last call went out on Aug. 8, 2025. We received 198 total complete, unique responses—158 from the US and 40 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey. 

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server. 

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report” is the definitive resource for understanding the global ophthalmic diagnostic landscape. This edition delivers in-depth analysis of the current markets for diagnostic equipment in cataract and refractive surgery, refracting and screening instruments, and emerging technologies. It also provides five-year global forecasts, along with regional and economic analyses across the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and developing markets worldwide. 

The report considers more than 800 devices from 115 manufacturers, covering technologies that span corneal topographers, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and advanced microscopy systems. 

Each section includes market sizing, pricing trends, competitor market share, installed equipment base, and company profiles, giving manufacturers, investors, and eye care providers the actionable intelligence needed to navigate competitive dynamics, plan strategic growth, and anticipate technological innovation.  

The 2025 Refractive Surgery Market Report provides a comprehensive view of the global refractive and presbyopia-correcting surgical market, highlighting the trends, drivers, and opportunities shaping the next five years. The report analyzes LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and emerging technologies poised to disrupt the market. 

It examines key participants in this segment, including prospective patients, refractive surgeons, laser centers, manufacturers of excimer and femtosecond lasers, mechanical microkeratomes, diagnostic equipment, and other presbyopia-correcting technologies.  

The report provides unit and revenue forecasts, market share analysis, and in-depth profiles of 15 leading competitors, including product portfolios, strategic positioning, company background, and outlook. 

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends.